Nalmefene Hydrochloride Oral Tablets Suppliers & Bulk Manufacturers
Available Forms: Oral Tablets
Available Strengths: 18 mg
Reference Brands: Selincro(EU)
Category: Antipsychotropic Drugs
Nalmefene Hydrochloride Oral Tablets is available in Oral Tablets and strengths such as 18 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Nalmefene Hydrochloride Oral Tablets is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Nalmefene Hydrochloride Oral Tablets can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description:
Nalmefene Hydrochloride Tablets are approved in the EU for the reduction of alcohol consumption in adult patients with alcohol dependence, under brand names like Selincro®. They are prescription-only and regulated by the European Medicines Agency (EMA) under centralized procedures. In the USA, as of now, Nalmefene tablets are not FDA-approved for alcohol dependence, though clinical trials have been conducted. EU regulatory approval includes risk management plans and post-marketing surveillance. Manufacturing requires adherence to EU-GMP guidelines. Pharmatradz.com connects you with compliant suppliers of Nalmefene Hydrochloride tablets and other psychiatric formulations for global B2B sourcing and regulatory insight.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Amisulpride
Strength:
5 mg/2 mL, 50 mg, 100 mg, 200 mg
Form: Tablets / injectable solutions
Reference Brands: Barhemsys (USA), Solian (EU)
View Details
Risperidone Long-Acting Injection
Strength:
12.5 mg, 25 mg, 37.5 mg, 50 mg vials/syringes
Form: Long-Acting Injection
Reference Brands: Risperdal Consta(US &EU)
View Details
Zuclopenthixol Ong-Acting Im Injection (Depot)
Strength:
200 mg/mL, 500 mg/mL
Form: Long-acting IM Injection (Depot)
Reference Brands: Clopixol Depot®(US)
View Details
Zuclopenthixol Short-Acting Intramuscular Injection
Strength:
50 mg/mL
Form: Short-acting Intramuscular Injection
Reference Brands: Clopixol-Acuphase®
View DetailsQuick Response Guaranteed | Verified Suppliers
